- GlobeNewswire•15 hours agoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Taro Pharmaceutical Industries Ltd. - TARO
NEW YORK, Dec. 02, 2016-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Taro Pharmaceutical Industries Ltd. securities from ...
- PR Newswire•22 hours agoTARO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Taro Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of December 27, 2016
NEW YORK, Dec. 2, 2016 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who ...
- Business Wire•2 days ago
Taro Pharmaceutical Industries Ltd. announced today that its Board of Directors has appointed Mr. Abhay Gandhi to the position of Interim Chief Executive Officer, effective January 1, 2017.
TARO : Summary for Taro Pharmaceutical Industries - Yahoo Finance
Taro Pharmaceutical Industries Ltd. (TARO)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||103.52 x 300|
|Ask||103.70 x 100|
|Day's Range||99.67 - 103.86|
|52 Week Range||92.28 - 157.99|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||8.18|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|